Limited access to CVD medicines in low-income and middle-income countries: poverty is at the heart of the matter
Main Authors: | Charles Agyemang, Bert-Jan van den Born |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X18300482 |
Similar Items
-
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
by: Chaoyang Li, et al.
Published: (2024-01-01) -
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
by: Chaoyang Li, et al.
Published: (2024-01-01) -
Evidence-based medicine in low-income and middle-income countries
by: Sudeep Adhikari
Published: (2021-07-01) -
Access to medicines for acute illness in middle income countries in Central America
by: Isabel Cristina Martins Emmerick, et al.
Published: (2013-12-01) -
Financial Inclusion, Poverty, and Income Inequality: Evidence from High, Middle, and Low-income Countries
by: Driss Tsouli
Published: (2022-03-01)